A Study of Efficacy and Safety of Idebenone vs. Placebo in Prodromal Parkinson Disease

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
To investigate whether 24 months of idebenone may reduce the progression from Prodromal Parkinson disease (PPD) to Parkinson disease (PD).
Epistemonikos ID: 9f4601f7606b37f0a8be9060afe8912f4b05cd23
First added on: May 06, 2024